Read + Share
Arai J, Hayakawa Y, Tateno H, Murakami K, et al. Impaired glycosylation of gastric mucins drives gastric tumorigenesis and serves
as a novel therapeutic target. Gastroenterology 2024 Apr 5:S0016-5085(24)00363.
PMID: 38583723
|
 |
|
Arai J, Hayakawa Y, Tateno H, Murakami K, et al. Impaired glycosylation of gastric mucins drives gastric tumorigenesis and serves
as a novel therapeutic target. Gastroenterology 2024 Apr 5:S0016-5085(24)00363.
PMID: 38583723
|
|
|
|